Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects

被引:0
|
作者
Weng, Hao-Jui [1 ,2 ,3 ]
Quoc Thao Trang Pham [3 ,4 ]
Chang, Chia-Wei [2 ]
Tsai, Tsen-Fang [5 ]
机构
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Dermatol, New Taipei 23561, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Dermatol, Taipei 11031, Taiwan
[3] Taipei Med Univ, Coll Med, Int PhD Program Cell Therapy & Regenerat Med, Taipei 11031, Taiwan
[4] Univ Med & Pharm Ho Chi Minh City, Fac Med, Dept Dermatol, Ho Chi Minh City 70000, Vietnam
[5] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 100225, Taiwan
关键词
pain; pruritus; neuropathy; NERVE GROWTH-FACTOR; ACTIVATED RECEPTOR 2; TOXIN TYPE-A; HISTAMINE-INDUCED ITCH; OPIOID-INDUCED ITCH; ATOPIC-DERMATITIS; NEUROPATHIC PAIN; SECONDARY HYPERALGESIA; DOUBLE-BLIND; POSTHERPETIC NEURALGIA;
D O I
10.3390/ph15070892
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pain and itch are both important manifestations of various disorders, such as herpes zoster, atopic dermatitis, and psoriasis. Growing evidence suggests that both sensations have shared mediators, overlapping neural circuitry, and similarities in sensitization processes. In fact, pain and itch coexist in some disorders. Determining pharmaceutical agents and targets for treating pain and itch concurrently is of scientific and clinical relevance. Here we review the neurobiology of pain and itch and discuss the pharmaceutical targets as well as novel compounds effective for the concurrent treatment of these sensations.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] In Silico Investigation of Gastroprotective Compounds from n-Butanol Fraction of Costus igneus on Antiulcer Druggable Targets
    Adetayo, Modupe O.
    Anyasor, God'swill N.
    FASEB JOURNAL, 2022, 36
  • [42] Illuminating the druggable genome: Linking diseases, targets and drugs
    Oprea, Tudor
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [43] Richter Syndrome: From Molecular Pathogenesis to Druggable Targets
    Mouhssine, Samir
    Gaidano, Gianluca
    CANCERS, 2022, 14 (19)
  • [44] In search of druggable targets for GBM amino acid metabolism
    Eduard H. Panosyan
    Henry J. Lin
    Jan Koster
    Joseph L. Lasky
    BMC Cancer, 17
  • [45] Putative druggable targets for selective enhancement of cardiac conduction
    Gomes, John
    Lambiase, Pier D.
    CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (02) : 154 - 159
  • [46] Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
    Baldelli, Elisa
    El Gazzah, Emna
    Moran, John Conor
    Hodge, Kimberley A.
    Manojlovic, Zarko
    Bassiouni, Rania
    Carpten, John D.
    Ludovini, Vienna
    Baglivo, Sara
    Crino, Lucio
    Bianconi, Fortunato
    Dong, Ting
    Loffredo, Jeremy
    Petricoin, Emanuel F.
    Pierobon, Mariaelena
    GENES, 2021, 12 (09)
  • [47] Unveiling the druggable RNA targets and small molecule therapeutics
    Sztuba-Solinska, Joanna
    Chavez-Calvillo, Gabriela
    Cline, Sabrina Elizabeth
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (10) : 2149 - 2165
  • [48] Intestinal Enteroendocrine Cells: Present and Future Druggable Targets
    Atanga, Roger
    Singh, Varsha
    In, Julie G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [49] Identifying New Drug Targets by Illuminating the Druggable Genome
    Sharma, Karlie
    Nadler, Laurie
    FASEB JOURNAL, 2021, 35
  • [50] SALMONELLABASE - An online database of druggable targets of Salmonella species
    Pushpa, Ophilia Benedict
    Suresh, Muthaiyan Xavier
    BIOINFORMATION, 2012, 8 (15) : 734 - 737